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The studies performed in laboratory animals and psychiatric patients suggest a possible role
of limbic system-associated membrane protein (LAMP) in the mechanisms of psychiatric
disorders. Stressful manipulations and genetic invalidation have revealed a role of the
Lsamp gene in the regulation of anxiety in rodents. Besides that, Lsamp-deﬁcient
mice display reduced aggressiveness and impaired adaptation in novel and stressful
environments.The behavioral effects of amphetamine were blunted in genetically modiﬁed
mice. Recent pharmacological and biochemical studies point toward altered function
of GABA-, 5-hydroxytryptamine-, and dopaminergic systems in Lsamp-deﬁcient mice.
Moreover, we found an association between the gene polymorphisms of LSAMP and
major depressive disorder (MDD). Patients suffering from MDD had signiﬁcantly increased
ratio between risk and protective haplotypes of the LSAMP gene compared to healthy
volunteers. However, the impact of these haplotypes for the function of LAMP is not clear
and remains to be elucidated in future studies.
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INTRODUCTION
The limbic system-associated membrane protein (LSAMP) gene
gives rise to LAMP, which is a 64- to 68-kDa heavily glycosylated
protein, structurally characterized by three immunoglobulin (Ig)
domains (Pimenta et al., 1996). LAMP protein is expressed on the
surface of somata and proximal dendrites of neurons (Zacco et al.,
1990) where it integrates via glycosyl-phosphatidyl-inositol (GPI)
anchor (Pimenta et al., 1996). LAMP protein has been shown to be
speciﬁc to the cortical and sub-cortical limbic-associated regions
(e.g., perirhinal cortex, cingulate cortex, amygdala, hippocam-
pus, and striatum) of the developing and adult brain (Levitt,
1984; Horton and Levitt, 1988; Pimenta et al., 1996; Reinoso
et al., 1996). Despite the name, LAMP is not expressed only in
the limbic-associated areas, but also less intensely in the midbrain
and hindbrain regions (Reinoso et al., 1996). A 99% amino acid
sequence identity between human and rodent LAMP (Pimenta
et al., 1996) indicates strong phylogenetic conservation of the pro-
tein structure and associated functional properties. Several cell
culture experiments suggest that LAMP mediates axon targeting
and growth in the brain (Keller et al., 1989; Pimenta et al., 1995;
Mann et al., 1998; Gil et al., 2002).
FUNCTIONAL STUDIES DEMONSTRATING A ROLE OF THE
Lsamp GENE IN THE REGULATION OF EMOTIONAL BEHAVIOR
The ﬁrst evidence for a role of the Lsamp gene in the regulation of
emotional behavior came froma studywheremaleWistar ratswere
selected according to their exploratory behavior in the elevated
plus-mazemodel of anxiety. Animalswith lower exploratory activ-
ity (increased anxiety) had elevated levels of the Lsamp transcript
in the periaqueductal gray (Nelovkov et al., 2003). In the same
rats, an increase of Lsamp gene expression was also noticed in the
amygdala, but not in the frontal cortex (Nelovkov et al., 2006).
Exposure of rats to cat odor, another model of anxiety in rodents,
also increased the expression of Lsamp transcript in the amyg-
dala (Kõks et al., 2004). These ﬁndings were extended by Alttoa
et al. (2010) demonstrating that the transcript for Lsamp was
more expressed in the raphe, hippocampus, and frontal cortex
of rats displaying reduced exploratory activity in the motility box.
Lamprecht et al. (2009) established that fear conditioning caused
changes in the Lsamp transcript expression in the amygdala of
rats. Altogether, rodent studies indicate that increased level of the
Lsamp transcript in several brain areas is related with increased
trait anxiety (Nelovkov et al., 2003, 2006; Alttoa et al., 2010), acute
fear reaction (Kõks et al., 2004), and fear conditioning (Lamprecht
et al., 2009).
EVIDENCE FROM STUDIES WITH Lsamp-DEFICIENT MICE
SUPPORTING ITS ROLE IN THE REGULATION OF EMOTIONAL
BEHAVIOR
Two different Lsamp gene knockout mouse lines have been cre-
ated. The ﬁrst (Catania et al., 2008) was created by deleting exon 2
and the mice were back-crossed more than 10 generations onto the
C57BL/6J background. The second (Innos et al., 2011) was created
by our research team by deleting exon 1b and we used F2 hybrids
[(129S6/SvEvTac × C57BL/6) × (129S6/SvEvTac × C57BL/6)] for
the behavioral experiments, because the congenic footprint effect
does not allow to achieve a pure background by backcrossing and
besides, it has been argued that a robust behavioral phenotype,
detectable over and above the behavioral variability caused by
a mixed genetic background, obviates the need for back-crosses
(Schalkwyk et al., 2007). Several cell culture experiments suggest
that LAMPmediates axon targeting and growth in the brain (Keller
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et al., 1989; Mann et al., 1998; Gil et al., 2002). However, obvious
lack of deviations in the brain organization of Lsamp-deﬁcient
mouse line, lacking exon 2 of the Lsamp gene, revealed that LAMP
is rather mediating ﬁnely specialized aspects of circuit formation
and maturation of the limbic system (Catania et al., 2008). These
two mouse lines have remarkably similar phenotypes: both display
no changes in sensory and motor development, are slightly hyper-
active in novel environments, and perform more open arm entries
and head-dips, and spend more time on open arms in the elevated
plus-maze. However, there are also differences between the phe-
notypes: the ﬁrst Lsamp gene knockout mouse line, generated in
the Vanderbilt University (U.S.A.), exhibited a pronounced deﬁcit
in spatial memory acquisition in the water maze and poorly sus-
tained CA1 long-term potentiation (Qiu et al., 2010). The second
Lsampgene knockoutmouse line, generated byus, performednor-
mally in the water maze and also displayed no learning deﬁciencies
in the active avoidance test, another learning paradigm (Innos
et al., 2011). We have also seen several unique phenotypic differ-
ences in our Lsamp gene knockout mice, such as decreased body
weight, lack of whisker trimming, decreased aggressive behavior
and reduced swimming speed (Innos et al., 2011). Apossible expla-
nation for the reduced agonistic and aggressive behavior could
be the increased tone of 5-hydroxytryptamine (5-HT) system in
the forebrain structures established in male Lsamp-deﬁcient mice
(Innos et al., 2013).
In the pharmacological studies we have found that the anx-
iolytic effect of diazepam is stronger in Lsamp-deﬁcient mice
compared to their wild-type littermates. Moreover, the ratio of
GABAA receptor subunit genes is shifted in favor of the alpha2
subunit compared to the alpha1 subunit in the temporal lobe
of Lsamp-deﬁcient mice. This could be a possible reason for
the reduced anxiety as well as the increased anxiolytic effect of
diazepam in Lsamp-deﬁcient mice (Innos et al., 2011). Besides
that the motor stimulant effect of amphetamine was signiﬁ-
cantly weaker in young Lsamp-deﬁcient mice (Innos et al., 2013).
Moreover, amphetamine did not cause place preference in these
mice. The reduced action of amphetamine was accompanied by
reduced expression of dopamine transporter, a major target of
amphetamine, gene in the mesencephalon. The reduced behav-
ioral effects were accompanied by increased levels and reduced
turnover of 5-HT in the forebrain structures in response to
amphetamine administration (Innos et al., 2013). Altogether, our
recent pharmacological and biochemical studies point toward
changes in the function of GABA-, 5-HT-, and dopaminergic
systems in Lsamp-deﬁcient mice.
INFLUENCE OF ENVIRONMENTAL MANIPULATIONS ON THE
BEHAVIOR OF Lsamp-DEFICIENT MICE
In order to study the impact of environmental manipulations on
the phenotype, we exposed male Lsamp-deﬁcient mice to environ-
mental enrichment (EE), a technique that has often been shown
to abolish phenotypic deviations in knockout mice, and to social
isolation, a stressful manipulation, after which all the mice were
tested in a behavioral battery. EE abolished differences between
the genotypes in body weight and anogenital snifﬁng, a behav-
ior related to aggressiveness, and ampliﬁed the anxiolytic-like
phenotype of Lsamp-deﬁcient mice both in the plus-maze and
motility box (Innos et al., 2012). Isolation abolished differences
between the genotypes in body weight and anxiety and ampliﬁed
the differences in swimming speed and anogenital snifﬁng. EE and
isolation failed tomodify the results as compared to standardhous-
ing in whisker trimming, locomotor activity, marble burying, and
corticosterone levels. In conclusion, Lsamp-deﬁcient mice were
less sensitive to isolation stress than their wild-type littermates.
Lack of LAMP protein seemingly leads to a deterioration in the
ability to adapt to novel stressful environments and stimuli (Innos
et al., 2012).
GENE POLYMORPHISM STUDIES DEMONSTRATING A ROLE
OF LSAMP IN MOOD DISORDERS
Human data link LSAMP not only with anxiety, but also with a
wider spectrum of psychiatric disorders: polymorphisms in the
human LSAMP gene have been associated with panic disorder
(PD; Koido et al., 2006) and male completed suicide (Must et al.,
2008). Furthermore, the levels of LAMP protein have been found
to be approximately 20% increased in postmortem frontal cortex
both in patients with schizophrenia and bipolar disorder (Behan
et al., 2009).
Our recent studies indicate that the LSAMP gene is possi-
bly related to major depressive disorder (MDD) and PD (Koido
et al., 2012). We detected statistically signiﬁcant allelic associations
between four LSAMP SNPs and MDD. Two SNPs out of these four
contributed to the increased risk (rs1461131 and rs4831089) and
two were protective (rs16824691 and rs9874470). Interestingly, all
associated SNPs in our study reside in the ﬁrst intron (1b) and
may affect the regulation of gene expression. Only two risk SNPs
above were related to PD. Haplotype block was formed from the
forenamed SNPs giving three statistically signiﬁcant haplotypes in
the MDD group: TATA was a risk haplotype, whereas CGAG and
CGTG were protective haplotypes. The risk haplotype TATA was
also statistically signiﬁcant in the PD group (Koido et al., 2012).
On a closer analysis of frequencies of minor alleles of haplotype
block, the risk haplotype TATA appeared more frequently than
the protective haplotypes CGAG and CGTG in the MDD group
(41 vs 24%) as compared to their respective control group (31 vs
33%; Pearson’s Chi square 10.96, P = 0.0009; Koido et al., 2012).
The same trend was observed in the PD group where the risk hap-
lotype TATA was more frequent than the protective haplotypes
CGAG and CGTG (38 vs 28%) as compared to their respective
control group (31 vs 34%). However, the difference in the case of
PD did not reach to the level of statistical signiﬁcance (Pearson’s
Chi square 3.37, P = 0.066). Therefore, this study (Koido et al.,
2012) underlines a signiﬁcantly stronger relation of the LSAMP
gene polymorphisms to MDD than to PD.
STATE OF ART
In conclusion, the studies described above, performed in labora-
tory animals and psychiatric patients, suggest a possible role of
LAMP in the mechanisms of psychiatric disorders. The Lsamp
gene seems to be involved in the regulation of emotional behavior
in rodents as the elevated function of the Lsamp gene is accom-
panied with increased anxiety, whereas the genetic invalidation
of the Lsamp gene leads to the reduction of anxiety in rodents.
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There is also a shift in the expression of GABAA receptor sub-
units in favor of alpha2. This could be a reason for the reduced
anxiety and increased anxiolytic action of diazepam in Lsamp-
deﬁcient mice (Innos et al., 2011). Furthermore, the adaptation of
Lsamp-deﬁcient mice is impaired in novel and stressful environ-
ments and theydisplay reduced aggressiveness. Also, their response
to the behavioral effects of amphetamine is blunted (Innos et al.,
2013). These behavioral effects are most likely related to changes
in the function of the 5-HT-ergic system in Lsamp-deﬁcient mice.
Besides that we found a relation between gene polymorphisms of
the LSAMP gene and MDD (Koido et al., 2012). Patients suffer-
ing from MDD have signiﬁcantly increased ratio between the risk
and protective haplotypes of the LSAMPgene compared to healthy
subjects. The impact of these haplotypes for the function of LAMP
is not clear and remains to be elucidated in future studies.
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